Skip navigation

Benchmark with International Peers to Gauge RBM Performance, Efficiencies, Implementation and Technologies

September 13-14, 2018
  • London, United Kingdom

With a surge of new technologies and trial models being implemented, the time is now to capitalise on industry expertise to capture the cost and efficiency benefits of risk-based monitoring.

Join us in London for CBI’s 3rd annual Global Risk Based Monitoring to gain robust strategies that will aid in reducing the complexities of implementing efficient RBM methodologies and gain real-life study examples from leading industry experts on your most pressing challenges, such as risk strategies, key data identification, evaluation, control, review and reporting.

Benchmark Against Industry Leaders To:

  • Weigh the newest technologies being implemented to
    support risk based monitoring in trials
  • Analyse requirements for a formal corrective action
    preventative action (CAPA) process for ensuring clinical trial
    management improvement following non-compliance
  • Evaluate implementation approaches, challenges and
    solutions for in-sourced, outsourced and hybrid models to RBM
  • Assess the impact changes to trial oversight on CROs,
    sites and clinical staff
  • Overcome common bottlenecks preventing full
    realization of RBM benefits
  • Gain international perspectives on how major
    pharmaceutical and CRO’s have implemented RBM

Previous Attendee Acclaim:

Good Balance of presentations, nice to hear multiple views from same company, gave more in depth view.

Consultant, Risk Based Approach Ltd

A very interesting conference specialized on
RBM and central monitoring.

Senior Director, Monitoring & Data Flow Optimization, Covance

Very interesting conference and engaged attendees. Great speakers for RBM discussion.


Great opportunity for networking and sharing best practices and common obstacles.


Great program!!!

Senior GCP Advisor, Novo Nordisk